{"id":20957,"date":"2011-09-10T09:29:59","date_gmt":"2011-09-10T12:29:59","guid":{"rendered":"http:\/\/www.inclusive.org.br\/?p=20957"},"modified":"2011-09-10T09:29:59","modified_gmt":"2011-09-10T12:29:59","slug":"laboratorio-roche-comeca-a-fase-inicial-estudo-clinico-em-pessoas-com-sindrome-de-down","status":"publish","type":"post","link":"https:\/\/inclusivenews.com.br\/?p=20957","title":{"rendered":"Laborat\u00f3rio Roche come\u00e7a a fase inicial estudo cl\u00ednico em pessoas com s\u00edndrome de Down"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-full wp-image-20958\" title=\"DSRTF logo\" src=\"http:\/\/inclusivenews.com.br\/wp-content\/uploads\/DSRTF-White-logo.png\" alt=\"\" width=\"300\" height=\"133\" \/><em>Esta \u00e9 a primeira terapia potencial para melhorar a cogni\u00e7\u00e3o e comportamento adaptativo em indiv\u00edduos com s\u00edndrome de Down. A Down Syndrome Research and Treatment Foundation (DSRTF) vem colaborando com o laborat\u00f3rio neste estudo.<\/em><\/p>\n<p>O laborat\u00f3rio Roche anunciou hoje o in\u00edcio de seu primeiro estudo de fase 1 cl\u00ednica para investigar a seguran\u00e7a e tolerabilidade de uma mol\u00e9cula projetada para atender os d\u00e9ficits cognitivos e comportamentais associados \u00e0 s\u00edndrome de Down.<\/p>\n<p>&#8220;H\u00e1 atualmente uma\u00a0grande\u00a0necessidade m\u00e9dica ainda n\u00e3o atendida para o tratamento de problemas cognitivos em indiv\u00edduos com s\u00edndrome de Down&#8221;, comenta Luca Santarelli, diretor global da Roche \u00c1rea de\u00a0Neuroci\u00eancia de\u00a0Doen\u00e7as Translacionais.\u00a0&#8220;A\u00a0estrat\u00e9gia da\u00a0Roche Neuroci\u00eancias \u00e9 abordar especificamente essas condi\u00e7\u00f5es graves que n\u00e3o t\u00eam\u00a0tratamento\u00a0efetivo ou seguro.\u00a0\u00c9 por isso que temos um forte compromisso com quest\u00f5es do desenvolvimento neurol\u00f3gico, incluindo ocorr\u00eancias gen\u00e9ticas, como s\u00edndrome de Down ou X Fr\u00e1gil, assim como transtornos do espectro autista. &#8221;<\/p>\n<p>A melhora das fun\u00e7\u00f5es cerebrais, tais como cogni\u00e7\u00e3o e linguagem em indiv\u00edduos com s\u00edndrome de Down, pode contribuir para que estes indiv\u00edduos a levem uma vida mais independente.\u00a0Isto pode ajudar, por exemplo, em habilidades pr\u00e1ticas de cada dia, tais como manter uma casa, ou um emprego e ter uma vida\u00a0social\u00a0mais gratificante.\u00a0Estas melhorias podem ter um impacto significativo sobre o funcionamento e a qualidade de vida de indiv\u00edduos com s\u00edndrome de Down, bem como ajudar a reduzir os encargos para as fam\u00edlias, cuidadores e a sociedade.<\/p>\n<p>&#8220;Este estudo ter\u00e1 como alvo apenas adultos entre 18 e 30 anos, mas acreditamos que uma interven\u00e7\u00e3o mais precoce na s\u00edndrome de Down tem o potencial para um maior resultado m\u00e9dico&#8221;, diz Paulo Fontoura, chefe de Medicina Translacional na \u00e1rea de Doen\u00e7as Roche Neuroci\u00eancias Translacional.\u00a0&#8220;Por enquanto ainda estamos na fase inicial, mas estamos confiantes de que nosso medicamento e mecanismo de a\u00e7\u00e3o pode, potencialmente, abrir a porta para novas investiga\u00e7\u00f5es promissoras nos pr\u00f3ximos anos.<\/p>\n<p>&#8220;Com base em modelos animais, um desequil\u00edbrio entre neurotransmiss\u00e3o excitat\u00f3rios e inibit\u00f3rios foi proposto entre as causas subjacentes da fun\u00e7\u00e3o cerebral alterada em indiv\u00edduos com s\u00edndrome de Down. O medicamento de investigado pela Roche est\u00e1 sendo avaliado por sua capacidade de lidar com este desequil\u00edbrio, a segmenta\u00e7\u00e3o do sistema * GABA\u00e9rgica.<\/p>\n<p>* GABA: gamma-amino \u00e1cido but\u00edrico<\/p>\n<p>Sobre o estudo<\/p>\n<p>Este estudo, controlado com placebo, ir\u00e1 avaliar a seguran\u00e7a e tolerabilidade do medicamento em investiga\u00e7\u00e3o em indiv\u00edduos com s\u00edndrome de Down.\u00a0Ele ir\u00e1 recrutar at\u00e9 33 indiv\u00edduos em um ou dois pa\u00edses.\u00a0A droga experimental j\u00e1 foi testada em volunt\u00e1rios saud\u00e1veis \u200b\u200be demonstraram uma boa seguran\u00e7a e tolerabilidade, sem eventos adversos significativos.\u00a0Para mais informa\u00e7\u00f5es sobre o estudo, o acesso a Roche clinicaltrials Protocolo de Registro e Banco de Dados Resultados: <a href=\"http:\/\/www.roche-trials.com\/\">http:\/\/www.roche-trials.com\/<\/a><\/p>\n<p>Sobre s\u00edndrome de Down<\/p>\n<p>A s\u00edndrome de Down \u00e9 a ocorr\u00eancia gen\u00e9tica mais comum de defici\u00eancia intelectual e atraso do desenvolvimento, e afeta uma em cada 700-1000 rec\u00e9m-nascidos.\u00a0Tamb\u00e9m chamada Trissomia do 21, esta condi\u00e7\u00e3o ocorre quando um indiv\u00edduo tem tr\u00eas, ao inv\u00e9s de duas, c\u00f3pias do cromossomo 21.\u00a0Este material adicional gen\u00e9tico traz algumas dificuldades de habilidade cognitiva e desenvolvimento f\u00edsico, e \u00e9 freq\u00fcentemente associado com outras complica\u00e7\u00f5es que v\u00e3o de quest\u00f5es neurol\u00f3gicos e card\u00edacas a problemas de audi\u00e7\u00e3o e vis\u00e3o.\u00a0Pessoas com s\u00edndrome de Down s\u00e3o mais propensas a desenvolver doen\u00e7a de Alzheimer \u00e0 medida que envelhecem.<\/p>\n<p>Para saber mais sobre o estudo e fazer doa\u00e7\u00f5es para contribuir para esta e outras pesquisas em s\u00edndrome de Down, visite o site da <a href=\"http:\/\/www.dsrtf.org\/\">DSRTF<\/a>.<\/p>\n<p>Fonte &#8211; Roche e <a href=\"http:\/\/www.dsrtf.org\/\">DSRTF<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Esta \u00e9 a primeira terapia potencial para melhorar a cogni\u00e7\u00e3o e comportamento adaptativo em indiv\u00edduos com s\u00edndrome de Down. A Down Syndrome Research and Treatment Foundation (DSRTF) vem colaborando com o laborat\u00f3rio neste estudo.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-container-style":"default","site-container-layout":"default","site-sidebar-layout":"default","disable-article-header":"default","disable-site-header":"default","disable-site-footer":"default","disable-content-area-spacing":"default","footnotes":""},"categories":[4],"tags":[],"class_list":["post-20957","post","type-post","status-publish","format-standard","hentry","category-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Laborat\u00f3rio Roche come\u00e7a a fase inicial estudo cl\u00ednico em pessoas com s\u00edndrome de Down -<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/inclusivenews.com.br\/?p=20957\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Laborat\u00f3rio Roche come\u00e7a a fase inicial estudo cl\u00ednico em pessoas com s\u00edndrome de Down -\" \/>\n<meta property=\"og:description\" content=\"Esta \u00e9 a primeira terapia potencial para melhorar a cogni\u00e7\u00e3o e comportamento adaptativo em indiv\u00edduos com s\u00edndrome de Down. A Down Syndrome Research and Treatment Foundation (DSRTF) vem colaborando com o laborat\u00f3rio neste estudo.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/inclusivenews.com.br\/?p=20957\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/agenciainclusive\/\" \/>\n<meta property=\"article:published_time\" content=\"2011-09-10T12:29:59+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/inclusivenews.com.br\/wp-content\/uploads\/DSRTF-White-logo.png\" \/>\n<meta name=\"author\" content=\"inclusivenews2024\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"inclusivenews2024\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/?p=20957#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/?p=20957\"},\"author\":{\"name\":\"inclusivenews2024\",\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/#\\\/schema\\\/person\\\/ae4ec7087559b8692fb33b6fffd2273b\"},\"headline\":\"Laborat\u00f3rio Roche come\u00e7a a fase inicial estudo cl\u00ednico em pessoas com s\u00edndrome de Down\",\"datePublished\":\"2011-09-10T12:29:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/?p=20957\"},\"wordCount\":675,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/?p=20957#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/inclusivenews.com.br\\\/wp-content\\\/uploads\\\/DSRTF-White-logo.png\",\"articleSection\":[\"NOT\u00cdCIAS\"],\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/inclusivenews.com.br\\\/?p=20957#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/?p=20957\",\"url\":\"https:\\\/\\\/inclusivenews.com.br\\\/?p=20957\",\"name\":\"Laborat\u00f3rio Roche come\u00e7a a fase inicial estudo cl\u00ednico em pessoas com s\u00edndrome de Down -\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/?p=20957#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/?p=20957#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/inclusivenews.com.br\\\/wp-content\\\/uploads\\\/DSRTF-White-logo.png\",\"datePublished\":\"2011-09-10T12:29:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/?p=20957#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/inclusivenews.com.br\\\/?p=20957\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/?p=20957#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/?p=20957#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/inclusivenews.com.br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Laborat\u00f3rio Roche come\u00e7a a fase inicial estudo cl\u00ednico em pessoas com s\u00edndrome de Down\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/#website\",\"url\":\"https:\\\/\\\/inclusivenews.com.br\\\/\",\"name\":\"Inclusive News\",\"description\":\"Inclusive News\",\"publisher\":{\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/inclusivenews.com.br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/#organization\",\"name\":\"Inclusive - inclus\u00e3o e cidadania\",\"url\":\"https:\\\/\\\/inclusivenews.com.br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/inclusivenews.com.br\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/@grandesite.png\",\"contentUrl\":\"https:\\\/\\\/inclusivenews.com.br\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/@grandesite.png\",\"width\":1080,\"height\":1080,\"caption\":\"Inclusive - inclus\u00e3o e cidadania\"},\"image\":{\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/agenciainclusive\\\/\",\"https:\\\/\\\/www.instagram.com\\\/newsinclusive\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/inclusivenews.com.br\\\/#\\\/schema\\\/person\\\/ae4ec7087559b8692fb33b6fffd2273b\",\"name\":\"inclusivenews2024\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c5a7ef84c66fa914f55bc4f7ce26cfa275a3b9a1c5568b907bd184fb4dde7b40?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c5a7ef84c66fa914f55bc4f7ce26cfa275a3b9a1c5568b907bd184fb4dde7b40?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c5a7ef84c66fa914f55bc4f7ce26cfa275a3b9a1c5568b907bd184fb4dde7b40?s=96&d=mm&r=g\",\"caption\":\"inclusivenews2024\"},\"sameAs\":[\"https:\\\/\\\/inclusivenews.com.br\"],\"url\":\"https:\\\/\\\/inclusivenews.com.br\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Laborat\u00f3rio Roche come\u00e7a a fase inicial estudo cl\u00ednico em pessoas com s\u00edndrome de Down -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/inclusivenews.com.br\/?p=20957","og_locale":"pt_PT","og_type":"article","og_title":"Laborat\u00f3rio Roche come\u00e7a a fase inicial estudo cl\u00ednico em pessoas com s\u00edndrome de Down -","og_description":"Esta \u00e9 a primeira terapia potencial para melhorar a cogni\u00e7\u00e3o e comportamento adaptativo em indiv\u00edduos com s\u00edndrome de Down. A Down Syndrome Research and Treatment Foundation (DSRTF) vem colaborando com o laborat\u00f3rio neste estudo.","og_url":"https:\/\/inclusivenews.com.br\/?p=20957","article_publisher":"https:\/\/www.facebook.com\/agenciainclusive\/","article_published_time":"2011-09-10T12:29:59+00:00","og_image":[{"url":"http:\/\/inclusivenews.com.br\/wp-content\/uploads\/DSRTF-White-logo.png","type":"","width":"","height":""}],"author":"inclusivenews2024","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"inclusivenews2024","Tempo estimado de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/inclusivenews.com.br\/?p=20957#article","isPartOf":{"@id":"https:\/\/inclusivenews.com.br\/?p=20957"},"author":{"name":"inclusivenews2024","@id":"https:\/\/inclusivenews.com.br\/#\/schema\/person\/ae4ec7087559b8692fb33b6fffd2273b"},"headline":"Laborat\u00f3rio Roche come\u00e7a a fase inicial estudo cl\u00ednico em pessoas com s\u00edndrome de Down","datePublished":"2011-09-10T12:29:59+00:00","mainEntityOfPage":{"@id":"https:\/\/inclusivenews.com.br\/?p=20957"},"wordCount":675,"commentCount":0,"publisher":{"@id":"https:\/\/inclusivenews.com.br\/#organization"},"image":{"@id":"https:\/\/inclusivenews.com.br\/?p=20957#primaryimage"},"thumbnailUrl":"http:\/\/inclusivenews.com.br\/wp-content\/uploads\/DSRTF-White-logo.png","articleSection":["NOT\u00cdCIAS"],"inLanguage":"pt-PT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/inclusivenews.com.br\/?p=20957#respond"]}]},{"@type":"WebPage","@id":"https:\/\/inclusivenews.com.br\/?p=20957","url":"https:\/\/inclusivenews.com.br\/?p=20957","name":"Laborat\u00f3rio Roche come\u00e7a a fase inicial estudo cl\u00ednico em pessoas com s\u00edndrome de Down -","isPartOf":{"@id":"https:\/\/inclusivenews.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/inclusivenews.com.br\/?p=20957#primaryimage"},"image":{"@id":"https:\/\/inclusivenews.com.br\/?p=20957#primaryimage"},"thumbnailUrl":"http:\/\/inclusivenews.com.br\/wp-content\/uploads\/DSRTF-White-logo.png","datePublished":"2011-09-10T12:29:59+00:00","breadcrumb":{"@id":"https:\/\/inclusivenews.com.br\/?p=20957#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/inclusivenews.com.br\/?p=20957"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/inclusivenews.com.br\/?p=20957#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/inclusivenews.com.br\/?p=20957#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/inclusivenews.com.br\/"},{"@type":"ListItem","position":2,"name":"Laborat\u00f3rio Roche come\u00e7a a fase inicial estudo cl\u00ednico em pessoas com s\u00edndrome de Down"}]},{"@type":"WebSite","@id":"https:\/\/inclusivenews.com.br\/#website","url":"https:\/\/inclusivenews.com.br\/","name":"Inclusive News","description":"Inclusive News","publisher":{"@id":"https:\/\/inclusivenews.com.br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/inclusivenews.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/inclusivenews.com.br\/#organization","name":"Inclusive - inclus\u00e3o e cidadania","url":"https:\/\/inclusivenews.com.br\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/inclusivenews.com.br\/#\/schema\/logo\/image\/","url":"https:\/\/inclusivenews.com.br\/wp-content\/uploads\/2024\/03\/@grandesite.png","contentUrl":"https:\/\/inclusivenews.com.br\/wp-content\/uploads\/2024\/03\/@grandesite.png","width":1080,"height":1080,"caption":"Inclusive - inclus\u00e3o e cidadania"},"image":{"@id":"https:\/\/inclusivenews.com.br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/agenciainclusive\/","https:\/\/www.instagram.com\/newsinclusive\/"]},{"@type":"Person","@id":"https:\/\/inclusivenews.com.br\/#\/schema\/person\/ae4ec7087559b8692fb33b6fffd2273b","name":"inclusivenews2024","image":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/secure.gravatar.com\/avatar\/c5a7ef84c66fa914f55bc4f7ce26cfa275a3b9a1c5568b907bd184fb4dde7b40?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c5a7ef84c66fa914f55bc4f7ce26cfa275a3b9a1c5568b907bd184fb4dde7b40?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c5a7ef84c66fa914f55bc4f7ce26cfa275a3b9a1c5568b907bd184fb4dde7b40?s=96&d=mm&r=g","caption":"inclusivenews2024"},"sameAs":["https:\/\/inclusivenews.com.br"],"url":"https:\/\/inclusivenews.com.br\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/inclusivenews.com.br\/index.php?rest_route=\/wp\/v2\/posts\/20957","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inclusivenews.com.br\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inclusivenews.com.br\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/inclusivenews.com.br\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inclusivenews.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20957"}],"version-history":[{"count":0,"href":"https:\/\/inclusivenews.com.br\/index.php?rest_route=\/wp\/v2\/posts\/20957\/revisions"}],"wp:attachment":[{"href":"https:\/\/inclusivenews.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20957"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inclusivenews.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20957"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inclusivenews.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20957"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}